Kim SJ, Kim MJ, Yoon SG, et al
Two patients chose to continue the medication despite the side effect
Beyond modest lipid improvements, GLP-1 receptor agonists have demonstrated substantial cardiovascular benefits in large-scale outcome trials, establishing them as important cardioprotective agents for appropriate patients
Nutrients 10 , 1638 (2018)
Mounjaro and Metformin: A Head-to-Head Comparison Emily Lawson Nov 3, 2024 3 min read Mounjaro (tirzepatide) and metformin are two prominent diabetes medications used to manage blood glucose levels in people with type 2 diabetes
The trials involved weight reduction through energy restriction, increased physical activity, or a combination of both